FENNEC PHARMACEUTICALS INC. (FENC) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin 11.27%.
- 2025-06-30: Pre-Tax Margin -32.66%.
Complete source-backed pre-tax margin history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | 11.27% |
| 2025-06-30 | -32.66% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -21.58% |
| 2024-12-31 | -0.15% |
| 2023-12-31 | -67.47% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |